<qa>  What is the first phase of the Phase II?- Phase II: Prior proteasome inhibitor andor Brutons tyrosine kinase inhibitors are allowed but patients may not have been exposed to the combination of proteasome inhibitor and BTK inhibitor. NOTE: Patients must have tolerated prior ibrutinib i.e., not discontinued therapy due to toxicity. 